However, in the NCG humanized mouse model (where immune function was restored in immunodeficient mice through intravenous PBMC injection), ADV-ApoA1 exhibited greater efficacy than ADV-Ctrl in impeding tumor growth, further emphasizing the crucial role of T cells in contributing to the anti-tumor effects of ADV-ApoA1. The gene discussed is APOA1; the disease is neoplasm.